Leptin, a hormonal product of the Lep gene, is expressed by adipocytes and
is thought to play a role in regulating food intake and reproduction. The l
eptin protein has been localized in many reproductive tissues, including th
e ovary. Several publications indicate that the ovary is directly affected
by leptin and that; leptin may be a factor linking obesity and reproductive
dysfunction. In this study, the effect of systemic leptin administration o
n ovulation in the rat ovary, both in vivo and in vitro, was investigated.
Ip administration of leptin (30 mu g at 3 hourly intervals for 15 h) to imm
ature gonadotropin-primed rats caused a decline in ovulation in vivo, from
15.9 +/- 2.0 oocytes in the control animals to 5.3 +/- 1.6 oocytes in the l
eptin-treated animals (P < 0.001). Plasma progesterone and estradiol levels
were analyzed immediately before ovulation, and neither was altered signif
icantly in animals receiving the leptin treatment. Food consumption and bod
y weight decreased following leptin treatment; however, a loss in body weig
ht alone (pair-fed controls) was insufficient to explain the decrease in ov
ulation observed in the leptin-treated animals. in vitro perfusion of FSH-p
rimed whole ovaries showed that treatment with leptin in combination with L
H significantly decreased ovulations from 5.7 +/- 1.6 per ovary perfused wi
th LH alone to 1.3 +/- 0.6 in those with LH and 1 mu g/ml leptin (P < 0.05)
. Progesterone and estradiol levels in the samples taken during the perfusi
on period were unaffected by leptin treatment. In summary, leptin administr
ation resulted in fewer ovulations, both in vivo and in vitro, but did not
influence steroid levels. Systemic leptin administration at these doses can
therefore inhibit ovulation, a process that occurs through a direct effect
on the ovary.